Stocks Taking Toll on Profitability Valuation: Novavax, Inc. (NASDAQ:NVAX)

Novavax, Inc. (NASDAQ:NVAX) under comprehensive financial analysis presented as an active mover. Shares knock down -1.37% to trade at $1.44 in recent trading session. The firm has floated short ration of 24.68%, hold to candle to sentiment indicator of Short Ratio, which was 10.33.

Limelight under Ratio Analysis

Novavax, Inc. (NASDAQ:NVAX) stands at price to sale ratio of 25.43 that signifies the value placed on each dollar of a firm’s sales or incomes; it is most relevant ratio to compare companies in similar sector.

Analysts Rating

Fundamentalist can give brighter side of a picture but an analyst can glow the darker parts stored in any investment. Let us view how analysts have ranked NVAX in recent few months. In ratings table the NVAX given BUY ratings by 1 analyst in current phase and 1 analyst suggest it as overweight security. While 6 number of analysts gave ratings for HOLD in current as compared to 1 analyst giving UNDERWEIGHT. As per remarks given by WSJ, overall consensus pool recommends it as Hold security.

The stock was assessed in terms of profitability as current quarter EPS estimate trends showed $-0.17 at current month while compared with $-0.16 in a month ago. The stock next year first quarter current estimate trend for EPS was for $-0.16 and on annual basis FY 2016 estimate trends at current was for $-0.62 as compared to one month ago of $-1.05, and for next year per share earnings estimates have $-0.64.

Profitability Analysis

The returns on assets were -56.80% that gives an idea about how efficient management is at using its assets to generate earnings. It has returns on equity of -329.60%, which is measuring profitability by disclosing how much profit generates by NVAX with the shareholders’ money.

The firm attains analyst recommendation of 2.70 on scale of 1-5. The co has price volatility of 3.58% for a week and 7.49% for a month. Narrow down focus to firm performance, its weekly performance was -2.04% and monthly performance was 9.09%. The stock price of NVAX is moving down from its 20 days moving average with -1.57% and isolated positively from 50 days moving average with 3.67%.

Novavax, Inc. (NASDAQ:NVAX) current ratio calculated as 4.30, this value is acceptable if it lies in 1.3% to 3%. But it varies industry to industry. To strengthen these views, active industry firm has Quick Ratio of 4.30, which indicates firm has sufficient short-term assets to cover its immediate liabilities.


About Blake Escott

Blake Escott holds junior writer position in SWR. Before joining Streetwise Report, he was a freelance content Writer. He has high-level copywriting experience and particularly experienced in proofreading and editing. He covers news about different companies including all US market sectors. Interests: Commodities, Energy stocks, Sector-wise Stocks analysis, Utilities

Leave a Reply

Your email address will not be published. Required fields are marked *